Drug intelligence / Profile preview

Drufusan N

Development stage: Unknown
Lead developer: Homeosyn Italia
Modality: Small Molecules
Administration: Oral

Overview

Drufusan N is a homeopathic preparation and nutraceutical developed by Homeosyn Italia Srl, available as an oral powder in sachets. The product contains a complex of 14 homeopathic mineral salts, including Acidum silicicum, various calcium salts, copper, iron, potassium, and sodium salts. It is marketed as a remineralizing supplement that helps balance mineral content in cells and acts as a biocatalyst activating over 300 enzymatic processes. Drufusan N is indicated for conditions such as osteoporosis, bone fracture healing, hair and nail fragility, iron-deficiency anemia, and dyslipidemia due to its cholesterol-lowering properties. It is suitable for a wide range of users, including children, athletes, and pregnant women.

Brand names: Drufusan N
Other names: DRUFUSAN N PolvereDRUFUSAN N powder

Beyond the preview

Go deeper on Drufusan N.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Drufusan N.

Explore the full profile